Cargando…

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

BACKGROUND: TP53 Arg72Pro (SNP rs1042522) is associated with risk of non-Hodgkin lymphoma (NHL). Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of NHL. However, the relationship between this SNP and prognosis of DLBCL in Asians is unknown. METHODS: Genotyping of TP53 Arg72Pro was d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yalu, Wang, Xiaogan, Ding, Ning, Mi, Lan, Ping, Lingyan, Jin, Xuan, Li, Jiao, Xie, Yan, Ying, Zhitao, Liu, Weiping, Zhang, Chen, Deng, Lijuan, Song, Yuqin, Zhu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680759/ https://www.ncbi.nlm.nih.gov/pubmed/29126407 http://dx.doi.org/10.1186/s12885-017-3760-0

Ejemplares similares

EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP
por: Li, Jiao, et al.
Publicado: (2017)

The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism
por: Ramos-Araque, Maria E., et al.
Publicado: (2018)

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma
por: He, Yizi, et al.
Publicado: (2019)

The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke
por: Gomez-Sanchez, Jose C., et al.
Publicado: (2011)

Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma
por: Fu, Zhiying, et al.
Publicado: (2014)

Arg72Pro Polymorphism of TP53 Gene and the Risk of Skin Cancer: a Meta-Analysis
por: Ye, Jun, et al.
Publicado: (2013)

Association Between Arg72Pro Polymorphism in TP53 and Malignant Abdominal Solid Tumor Risk in Hunan Children
por: Liu, Zan, et al.
Publicado: (2021)

Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population
por: Fu, Wen, et al.
Publicado: (2017)

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
por: YONEDA, TOMOKO, et al.
Publicado: (2013)

TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals
por: Kodal, Jakob B., et al.
Publicado: (2017)

Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis
por: Dong, Zhiyong, et al.
Publicado: (2018)

Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism
por: Rodríguez, Cristina, et al.
Publicado: (2017)

No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects
por: Zhang, Anqi, et al.
Publicado: (2017)

Association of XRCC1 Arg399GIn and Tp53 Arg72Pro polymorphisms and increased risk of uterine leiomyoma - A case-control study
por: Yaghmaei, Minoo, et al.
Publicado: (2015)

A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
por: Lin, Ningjing, et al.
Publicado: (2013)

The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies
por: Tian, Xin, et al.
Publicado: (2016)

TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients
por: Nairuz, Tahsin, et al.
Publicado: (2020)

Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers()
por: Li, Le, et al.
Publicado: (2019)

Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
por: Qin, Yan, et al.
Publicado: (2022)

Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies
por: Tian, Xin, et al.
Publicado: (2016)

TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case–control study
por: Fang, Yuan, et al.
Publicado: (2020)

TP53 Gene 72 Arg/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia
por: Ounalli, Asma, et al.
Publicado: (2023)

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
por: Liu, Yalu, et al.
Publicado: (2019)

Duplex Detection of TP53 Arg72Pro and 16 bp Del/Ins Polymorphisms by a Simple Optimized PCR-RFLP Method
por: Lajin, B, et al.
Publicado: (2012)

Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis
por: Jafrin, Sarah, et al.
Publicado: (2020)

Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment
por: Shen, Chiung-Chyi, et al.
Publicado: (2020)

The Association Between TP53 Arg72pro Polymorphism and Non-Melanoma Skin Cancer Risk: A Meta-Analysis Including 7,107 Subjects
por: Yang, Xueling, et al.
Publicado: (2013)

PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity
por: Zheng, Wen, et al.
Publicado: (2018)

The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females
por: Isakova, Jainagul, et al.
Publicado: (2017)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
por: Cavallone, Luca, et al.
Publicado: (2008)

TP53Gene Pro72Arg(rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population
por: Asadi, Milad, et al.
Publicado: (2017)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Sinilnikova, O M, et al.
Publicado: (2009)

TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population
por: Basabaeen, Ameen Abdulaziz Mohammed, et al.
Publicado: (2019)

TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
por: Johnson, William T., et al.
Publicado: (2023)

Increased Risk of Cutaneous Melanoma Associated with p53 Arg72Pro Polymorphism
por: Geng, Peiliang, et al.
Publicado: (2015)

Association between p53 Codon 72 (Arg72Pro) Polymorphism and Primary Open-Angle Glaucoma in Iranian Patients
por: Neamatzadeh, Hossein, et al.
Publicado: (2015)

Association of TP53 gene codon 72 polymorphism with endometriosis risk in Isfahan
por: Nikbakht Dastjerdi, Mehdi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1nofbpgh07ftqvhemtutv1i41j